Showing 35,441 - 35,460 results of 70,031 for search '(( 01 ((1 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 1.88s Refine Results
  1. 35441

    Complement to Fig 7—A p53-dependent response promotes tissue development when nuclear reassembly is compromised. by Jingjing Li (7654)

    Published 2024
    “…Right: Quantifications of wing sizes (<i>n</i> = 13 to 15). Scale bar: 1 mm. In panels A and B, Ankle2 RNAi line #1 (VDRC100655) was used. …”
  2. 35442
  3. 35443
  4. 35444
  5. 35445

    RPS reduced the size and number of tumors on the esophagus of rats exposed to NMBA. by Shu Yan (394046)

    Published 2015
    “…The average number of papilloma and carcinoma is presented, n = 10. * represents significant difference between NMBA group vs healthy control group, <i>P</i> < 0.01. # represents significant difference between NMBA +RPS group vs NMBA group, <i>P</i> < 0.01.…”
  6. 35446
  7. 35447
  8. 35448

    Use of Patient-Specific Instrumentation (PSI) for glenoid component positioning in shoulder arthroplasty. A systematic review and meta-analysis by Guillaume Villatte (5675465)

    Published 2018
    “…</p><p>Conclusion</p><p>This review supports the idea that PSI enhances glenoid component positioning, especially a decrease in the number of outliers. However, the findings are not definitive and further validation is required. …”
  9. 35449
  10. 35450

    Table_1_Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab.docx by Paulette Esperanza Walo-Delgado (11537425)

    Published 2021
    “…The AIAEs+ group continued having high percentages of PB/PC after a year of alemtuzumab treatment (p=0.0058).</p>Conclusions<p>A PB/PC percentage <0.1% at baseline identifies MS patients at low risk of secondary autoimmunity during alemtuzumab treatment.​…”
  11. 35451
  12. 35452
  13. 35453
  14. 35454
  15. 35455
  16. 35456
  17. 35457
  18. 35458
  19. 35459
  20. 35460

    MiR-210 negatively regulates aconitase and complex I activity in MCF7 and HCT116, and upregulates glycolysis. by Elena Favaro (249908)

    Published 2010
    “…<p>Cells transfected with siRNA against ISCU or with mimic-210 show a significant decrease in the activity of the Fe-S protein aconitase (<i>A</i>) and complex I (<i>B</i>) at 48 hrs. …”